SBIR-STTR Award

Production of a Value-Added Crop for Greater Human Nutrition
Award last edited on: 2/1/2013

Sponsored Program
SBIR
Awarding Agency
USDA
Total Award Amount
$540,000
Award Phase
2
Solicitation Topic Code
8.5
Principal Investigator
Mark P Elless

Company Information

Edenspace Systems Corporation (AKA: Phytotech Inc)

PO Box 2338
Purcellville, VA 20132
   (703) 961-8700
   ferns@edenspace.com
   www.edenspace.com
Location: Single
Congr. District: 10
County: Loudoun

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2009
Phase I Amount
$80,000
A. Situation or Problem The U.S. population has a deficit of dietary Ca, with 55% of men and 78% of women in the United States not meeting the US recommended daily allowance (RDA) for Ca of 1000 mg/d, putting them at risk for developing osteoporosis. One in two women and one in eight men over the age of 50 will have an osteoporosis-related fracture, resulting in more than $10 billion in health care costs annually. Because a low level of Ca in the diet is among the most important controllable causes of osteoporosis, early intervention in diet is crucial to addressing this important health problem. In the US, approximately 70% of dietary Ca is provided by dairy products such as milk and cheese, with only spinach, collards, or turnip greens as "good" sources of Ca. None of these vegetables forms a significant part of the average diet; however, a more popular vegetable such as lettuce provides only < 2% of the RDA for Ca per cup. Changing individual dietary preferences, for example to include different foods rich in Ca, is a slow and expensive process. In contrast, increasing the levels of vital minerals in dietary staples - such as iodine in salt, fluorine in drinking water, vitamin D in milk, and Ca and niacin in wheat flour - has been a rapid, cost-effective means of changing nutrition on a large scale. From this standpoint, vegetables represent an attractive means of providing increased nutrition to the public since their consumption for health purposes is already encouraged through information campaigns by public health organizations and several low-Ca vegetables (e.g., lettuce) are consumed at much higher levels than Ca-rich vegetables, increasing their value for delivery of increased nutrition. Aside from its large-scale production and consumption, lettuce is an attractive dietary option for enhancing consumption of dietary Ca because it is rich in vitamin K, a co-factor for Ca use in the body, and that one out of four women eat lettuce on any given day, showing that this vegetable is readily consumed by a major at-risk group for osteoporosis. B. Purpose This SBIR Phase I project proposes to develop a novel method of increasing Ca levels in lettuce, a vegetable that comprises a significant part of the average U.S. diet, by using a combination of genetic engineering and low-cost amendments. This Phase I project will demonstrate that these techniques can increase Ca uptake in lettuce to the point that it qualifies as a "good" dietary source of this mineral under USDA guidelines. Successful completion of the project should lay the foundation for introduction of a new value-added crop that provides better nutrition for consumers and a new source of income for agricultural producers. Given the scope of the U.S. dietary Ca deficit, it is highly likely that enhanced Ca content in popular vegetables such as lettuce could measurably improve the health of significant numbers of Americans. In this regard, Ca-fortified lettuce can be viewed as a dietary option for consumers who seek to elevate their intake of Ca without the need to replace favorite foods or rely on mineral supplements. OBJECTIVES: This SBIR Phase I project proposes to develop a novel method of increasing calcium (Ca) levels in two popular lettuce varieties that already comprise a significant part of the average U.S. diet, by combining the use of genetic engineering with low-cost hydroponic amendments. Currently, additional dietary calcium has been provided in the form of nutritional supplements; however, most of these supplements, which many consumers fail to take regularly, provide the calcium in a non-bioavailable, inorganic form that fails to be adequately metabolized in the human body. Increasing the calcium content of a popular vegetable that provides the additional calcium in bioavailable form will help to protect consumers against the onset of osteoporosis. The proposed research will address the following objectives: (i) Demonstrate that hydroponic chemical amendments, applied to transgenic lettuce, increase calcium content relative to control treatment by a factor of 2 or more, to the point that a single helping of lettuce (i.e., one cup) would contain about 250 mg of Ca, equivalent to 25% of the RDA for calcium per serving and sufficient to qualify as a "good" source of calcium by USDA, and (ii) Demonstrate good (75%) in vitro bioavailability of Ca in the transformed lettuce produced in (i). If successful, the enhanced lettuce plants will help to increase consumption of dietary calcium by consumers believed to be at risk for osteoporosis (e.g., post-menopausal women) as well as increase overall calcium levels in the diets of other consumers to take advantage of the bone-strengthening properties associated with higher levels of calcium intake. This research should provide the basis for a cost-effective, grower-based technology that increases the nutritional value of a food staple and which has a large commercial market in the U.S. and abroad

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
2011
Phase II Amount
$460,000
The U.S. population has a deficit of dietary calcium that represents a serious challenge to public health. Many consumers, however, find current methods of increasing dietary calcium to be inconvenient, costly, or unpalatable. This SBIR Phase II proposal seeks to increase calcium levels in lettuce, a specialty crop that already comprises a significant part of the average U.S. diet. Successful Phase I results included demonstration of the ability to provide up to 150 mg of calcium per serving of Bibb lettuce, a level high enough to qualify the lettuce as a "good" source of calcium under FDA guidelines and more than eight times the amount of calcium available in commercial lettuce today, using a combination of bioengineering and novel hydroponic techniques. Moreover, most of the calcium in the lettuce is present in a bioavailable form that is efficiently processed by the body. In Phase II, elite commercial lettuce varieties provided by a leading commercial seed company will be transformed, hydroponic growing protocols will be optimized, a pilot demonstration will be conducted at a commercial hydroponic lettuce grower, and product quality testing including taste testing will be conducted by a university partner. Successful completion of the project will lay the foundation for introduction of a new value-added crop that provides better nutrition for consumers and a new source of income for agricultural producers. Planned commercialization activities include marketing of the calcium-fortified lettuce at regional farmers' markets, followed by nationwide distribution through grocery chains and specialty food stores. OBJECTIVES: Specific objectives for the Phase II project have been identified: (i) Elite commercial lettuce varieties will be transformed and the transformed lettuce plants characterized as required for regulatory approval (e.g., quantifying protein levels, determining copy number, assessing allergenicity potential, etc.). (ii) Factors that might affect pilot-scale production of the fortified lettuce will be optimized (e.g., nutrient solution formulation, form and concentration of the calcium amendments, timing of initial application of the calcium amendments, and duration of application) for their effect on total and bioavailable calcium levels in the lettuce. (iii) Pilot-scale production of the fortified lettuce will be initiated at a local grower of hydroponic vegetables to assess growth behavior, calcium content, and projected cost under pilot-scale production conditions. (iv) Favorable taste and appearance of the transgenic lettuce compared to the control lettuce will be demonstrated using a sensory panel. Successful completion of this project should provide the basis for significantly reducing dietary calcium deficits while providing a high-margin, value added specialty crop for producers. The overall objective is to achieve bioavailable calcium levels of at least 75% of the total calcium concentration and total calcium levels of at least 100 mg/cup, so that the lettuce meet the government's criterion as a "good" source for calcium. Commercialization will be initiated following pilot-scale production of the fortified lettuce in Phase II. APPROACH: Several elite commercial lettuce varieties will be transformed with a transporter gene designed to enhance calcium accumulation into the lettuce. Genomic DNA will be extracted from leaf tissue to identify primary transformed plants using PCR primers specific to the region spanning the promoter and the transgene. Additional characterization includes quantification of the transgene, the copy number of the transgene, and generational expression of transgene over three generations of lettuce. Once characterized, seeds of each control and transgenic lettuce variety will be grown for treatment in a hydroponic system. Edenspace will test its proprietary formulation against three different proprietary blends used by other researchers for optimization of calcium accumulation. Additional studies will be conducted to optimize the form and concentration of the applied calcium, the effect of the growth stage of the lettuce on calcium uptake, and the effect of treatment duration. The harvested biomass will also be analyzed for levels of the undesirable, less-bioavailable oxalate form of calcium. Finally, a study with human volunteers will be used to demonstrate the probability of consumer acceptance of the fortified lettuce in terms of taste, appearance, shelf life, and price. All data generated during this study will be reviewed by Edenspace's QA officer to ensure the integrity of the data quality. Once the data quality has been ensured, data analysis consisting of mean comparisons will be initiated. Testing of individual hypotheses will be conducted to evaluate the performance of the transgene and hydroponic amendment to enhance total and bioavailable calcium levels of the transgenic vegetables compared to the controls. All hypothesis testing will be performed at an alpha level of 0.05. Means separation testing will be used to discern significant differences between individual treatment conditions as well as to the control. Results from this testing will identify the best combination of applied calcium form and concentration for meeting the project target of 100 mg per serving (i.e., 1 cup) of lettuce.